Rituximab treatment in children: Comment on the review by Looney et al.

Arthritis and Rheumatism

Volumn 58, Issue 8, 2008, Pages 2583-

  Bader Meunier, Brigitte ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; RITUXIMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CYTOPENIA; DRUG SUBSTITUTION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOCOMPETENCE; IMMUNOGLOBULIN DEFICIENCY; IMMUNOTHERAPY; LETTER; PRIORITY JOURNAL; SUBSTITUTION THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; AGE; BLOOD; CHILD; DRUG COMBINATION; IMMUNOLOGY; NOTE; PRESCHOOL CHILD; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL PRACTICE; CLINICAL TRIAL; PATIENT CARE;

ADOLESCENT; AGE FACTORS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS;

EID: 49449116285     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23690     Document Type: Letter

References (10)

1. Looney RJ, Srinivasan R, Calabrese LH. The effects of rituximab on immunocompetency in patients with autoimmune disease [review]. Arthritis Rheum 2008;1:5-14.
2. Quartier P, Brethon B, Philippet P, Landman-Parker J, Le Deist F, Fischer A. Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet 2001;358:1511-3.
3. Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 2003;101:3857-61.
4. Bennett CM, Rogers ZR, Kinnamon DD, Bussel JB, Mahoney DH, Abshire TC, et al. Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 2006;107:2639-42.
5. Bader-Meunier B, Aladjidi N, Bellmann F, Monpoux F, Nelken B, Robert A, et al. Rituximab therapy for childhood Evans syndrome. Haematologica 2007;92:1691-4.
6. Marks SD, Patey S, Brogan PA, Hasson N, Pilkington C, Woo P, et al. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arthritis Rheum 2005;52:3168-74.
7. Willems M, Haddad E, Niaudet P, Kone-Paut I, Bensman A, Cochat P, et al. Rituximab therapy for childhood-onset systemic lupus erythematosus. J Pediatr 2006;148:623-7.
8. Quartier P, Tournilhac O, Archimbaud C, Lazaro L, Chaleteix C, Millet P, et al. Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment. Clin Infect Dis 2003;36:e47-9.
9. Nwobi O, Abitbol CL, Chandar J, Seeherunvong W, Zilleruelo G. Rituximab therapy for juvenile-onset systemic lupus erythematosus. Pediatr Nephrol 2008;23:413-9.
10. Albert D, Dunham J, Khan S, Stansberry J, Kolasinski S, Tsai D, et al. Variability in the biological response to anti-CD20 B-cell depletion in SLE. Ann Rheum Dis 2008. E-pub ahead of print.